首页> 外文期刊>Personal and Ubiquitous Computing >Drug identification and interaction checker based on IoT to minimize adverse drug reactions and improve drug compliance
【24h】

Drug identification and interaction checker based on IoT to minimize adverse drug reactions and improve drug compliance

机译:基于物联网的药物识别和交互检查器,可最大程度减少药物不良反应并提高药物依从性

获取原文
获取原文并翻译 | 示例
           

摘要

Drug compliance and adverse drug reactions (ADR) are two of the most important issues regarding patient safety throughout the worldwide healthcare sector. ADR prevalence is 6.7 % throughout hospitals worldwide, with an international death rate of 0.32 % of the total of the patients. This rate is even higher in Ambient Assisted Living environments, where 15 % of the patients suffer clinically significant interactions due to patient non-compliance to drug dosage and schedule of intake in addition to suffering from polypharmacy. These instances increase with age and cause risks of drug interactions, adverse effects, and toxicity. However, with a tight follow-up of the drug treatment, complications of incorrect drug use can be reduced. For that purpose, we propose an innovative system based on the Internet of Things (IoT) for the drug identification and the monitoring of medication. IoT is applied to examine drugs in order to fulfill treatment, to detect harmful side effects of pharmaceutical excipients, allergies, liver/renal contradictions, and harmful side effects during pregnancy. The IoT design acknowledges that the aforementioned problems are worldwide so the solution supports several IoT identification technologies: barcode, Radio Frequency Identification, Near Field Communication, and a new solution developed for lowincome countries based on IrDA in collaboration with the World Health Organization. These technologies are integrated in personal devices such as smart-phones, PDAs, PCs, and in our IoT-based personal healthcare device called Movital.
机译:药物依从性和药物不良反应(ADR)是整个全球医疗保健领域中与患者安全有关的两个最重要的问题。全球各地医院的ADR患病率为6.7%,国际死亡率为所有患者的0.32%。在环境辅助生活环境中,该比率甚至更高,在该环境中,有15%的患者由于除药物治疗之外还不遵守药物剂量和服用时间表,遭受临床上显着的相互作用。这些情况会随着年龄的增长而增加,并引起药物相互作用,不良反应和毒性的风险。但是,通过严格的药物治疗跟踪,可以减少不正确用药的并发症。为此,我们提出了一种基于物联网(IoT)的创新系统,用于药物识别和药物监测。物联网用于检查药物以实现治疗,检测药物赋形剂的有害副作用,过敏,肝肾矛盾以及怀孕期间的有害副作用。物联网设计承认上述问题是全球性的,因此该解决方案支持多种物联网识别技术:条形码,射频识别,近场通信,以及与世界卫生组织合作基于IrDA为低收入国家开发的新解决方案。这些技术已集成到个人设备中,例如智能手机,PDA,PC,以及我们基于IoT的个人保健设备Movital。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号